Endothelio- and cardioprotective effects of vitamin B₆ and folic acid in modelling methionine-induced hyperhomocysteinemia

A new strategy to treat hyperhomocysteinemia

Geng Bin
Chang Lin
Du Jun-bao
Tang Chao-shu

January 2005

Hyperhomocysteinemia is an independent risk factor for cardiovascular diseases. At present, the main...

Homocysteine and coronary atherosclerosis

Mayer, Ellen L.
Jacobsen, Donald W.
Robinson, Killian

March 1996

AbstractHomocysteine is increasingly recognized as a risk factor for coronary artery disease. An und...

Hyperhomocysteinemia in developing age and nutritional aspects of folates: an early cardiovascular risk factor

Giuseppe Caramia
Romualdo Belardinelli

February 2016

elevated plasma levels of homocysteine are associated with an increased risk of atherosclerosis and ...

ENDOTHELIO- AND CARDIOPROTECTIVE EFFECTS OF VITAMIN В6 AND FOLIC ACID IN MODELLING METHIONINE-INDUCED HYPERHOMOCYSTEINEMIA

Provotorov, Vladimir
Korokin, Mikhail
Pokrovskii, Mikhail
Povetkin, Sergej
Lazareva, Galina
Stepchenko, Aleksandr
Bystrova, Natalya

March 2016

The endotelio- and cardioprotective effects of vitamin B6 (2 mg/kg) and folic acid (0.2 mg/kg) upon ...

Endothelio- and cardioprotective effects of vitamin B₆ and folic acid in modelling methionine-induced hyperhomocysteinemia

Provotorov, V. Y.
Korokin, M. V.
Pokrovskii, M. V.
Povetkin, S. V.
Lazareva, G. A.

May 2020

The endotelio- and cardioprotective effects of vitamin B₆ (2 mg/kg) and folic acid (0.2mg/kg) upon m...

Therapeutical approach to plasma homocysteine and cardiovascular risk reduction

Marcello Ciaccio
Giulia Bivona
Chiara Bellia

March 2008

Marcello Ciaccio, Giulia Bivona, Chiara BelliaDepartment of Medical Biotechnologies and Forensic Med...

The role of homocysteine in endothelial dysfunction

Visternicean, Elena

January 2017

Department of Obstetrics and Gynecology No 2, Nicolae Testemitsanu State University of Medicine and ...

Therapeutical approach on plasma homocysteine and cardiovascular risk reduction

Ciaccio, M.
Bivona, G.
Bellia, C.

January 2008

Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Since 1969 t...

Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction

CIACCIO, Marcello
BELLIA, Chiara

January 2010

Abstract Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Sin...

Methoxistasis: Integrating the Roles of Homocysteine and Folic Acid in Cardiovascular Pathobiology

Joseph Loscalzo
Jacob Joseph

August 2013

Over the last four decades, abnormalities in the methionine-homocysteine cycle and associated folate...

Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins

NAPPO F.
DE ROSA N.
MARFELLA, Raffaele
DE LUCIA D.
INGROSSO, Diego
PERNA, Alessandra
FARZATI B.
GIUGLIANO, Dario

January 1999

Context: Increased levels of homocysteine are associated with risk of cardiovascular disease. Homocy...

The effect of folic acid, vitamin B-6 and vitamin B-12 on the homocysteine levels in rabbits fed by methionine-enriched diets

Akcakus, Mustafa
Narin, Figen
Karakucuk, I
Halici, Canan
Narin, Nazmi
Ustdal, M

October 2002

Atherosclerosis is an important cause of cardiovascular morbidity and mortality in recent years. Hyp...

Effect at Short-Term Vitamin (Folic Acid, Vitamins B-6 and B-12) Administration on Endothelial Dysfunction Induced by Post-Methionine Load Hyperhomocysteinemia

趙嘉倫
CHAO, CHIA-LUN

September 2009

This study showed that short-term vitamin administration effectively reduced post-methionine load ho...

Use of selective inhibitors of arginase 2 and tadalafil in combined compensation of homocysteine-induced endothelial dysfunction

Koklin, I. S.

January 2015

Use of selective inhibitors of arginase 2 in combination with tadalafil on in the course of modeling...

Studying dose-dependent endothelio- and cardioprotective activity of selective arginase II inhibitor in hyperhomocysteineinduced endothelial dysfunction

Yakushev, V. I.
Filippenko, N. G.
Kizilova, I. V.
Korokin, M. V.
Beskhmelnitsyna, E. A.

January 2016

This paper deals with the study of endothelio- and cardioprotective activity ofarginase II selective...

A new strategy to treat hyperhomocysteinemia

Geng Bin
Chang Lin
Du Jun-bao
Tang Chao-shu

January 2005

Hyperhomocysteinemia is an independent risk factor for cardiovascular diseases. At present, the main...

Homocysteine and coronary atherosclerosis

Mayer, Ellen L.
Jacobsen, Donald W.
Robinson, Killian

March 1996

AbstractHomocysteine is increasingly recognized as a risk factor for coronary artery disease. An und...

Hyperhomocysteinemia in developing age and nutritional aspects of folates: an early cardiovascular risk factor

Giuseppe Caramia
Romualdo Belardinelli

February 2016

elevated plasma levels of homocysteine are associated with an increased risk of atherosclerosis and ...

ENDOTHELIO- AND CARDIOPROTECTIVE EFFECTS OF VITAMIN В6 AND FOLIC ACID IN MODELLING METHIONINE-INDUCED HYPERHOMOCYSTEINEMIA

Provotorov, Vladimir
Korokin, Mikhail
Pokrovskii, Mikhail
Povetkin, Sergej
Lazareva, Galina
Stepchenko, Aleksandr
Bystrova, Natalya

March 2016

The endotelio- and cardioprotective effects of vitamin B6 (2 mg/kg) and folic acid (0.2 mg/kg) upon ...

Endothelio- and cardioprotective effects of vitamin B₆ and folic acid in modelling methionine-induced hyperhomocysteinemia

Provotorov, V. Y.
Korokin, M. V.
Pokrovskii, M. V.
Povetkin, S. V.
Lazareva, G. A.

May 2020

The endotelio- and cardioprotective effects of vitamin B₆ (2 mg/kg) and folic acid (0.2mg/kg) upon m...

Therapeutical approach to plasma homocysteine and cardiovascular risk reduction

Marcello Ciaccio
Giulia Bivona
Chiara Bellia

March 2008

Marcello Ciaccio, Giulia Bivona, Chiara BelliaDepartment of Medical Biotechnologies and Forensic Med...

The role of homocysteine in endothelial dysfunction

Visternicean, Elena

January 2017

Department of Obstetrics and Gynecology No 2, Nicolae Testemitsanu State University of Medicine and ...

Therapeutical approach on plasma homocysteine and cardiovascular risk reduction

Ciaccio, M.
Bivona, G.
Bellia, C.

January 2008

Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Since 1969 t...

Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction

CIACCIO, Marcello
BELLIA, Chiara

January 2010

Abstract Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Sin...

Methoxistasis: Integrating the Roles of Homocysteine and Folic Acid in Cardiovascular Pathobiology

Joseph Loscalzo
Jacob Joseph

August 2013

Over the last four decades, abnormalities in the methionine-homocysteine cycle and associated folate...

Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins

NAPPO F.
DE ROSA N.
MARFELLA, Raffaele
DE LUCIA D.
INGROSSO, Diego
PERNA, Alessandra
FARZATI B.
GIUGLIANO, Dario

January 1999

Context: Increased levels of homocysteine are associated with risk of cardiovascular disease. Homocy...

The effect of folic acid, vitamin B-6 and vitamin B-12 on the homocysteine levels in rabbits fed by methionine-enriched diets

Akcakus, Mustafa
Narin, Figen
Karakucuk, I
Halici, Canan
Narin, Nazmi
Ustdal, M

October 2002

Atherosclerosis is an important cause of cardiovascular morbidity and mortality in recent years. Hyp...

Effect at Short-Term Vitamin (Folic Acid, Vitamins B-6 and B-12) Administration on Endothelial Dysfunction Induced by Post-Methionine Load Hyperhomocysteinemia

趙嘉倫
CHAO, CHIA-LUN

September 2009

This study showed that short-term vitamin administration effectively reduced post-methionine load ho...

Use of selective inhibitors of arginase 2 and tadalafil in combined compensation of homocysteine-induced endothelial dysfunction

Koklin, I. S.

January 2015

Use of selective inhibitors of arginase 2 in combination with tadalafil on in the course of modeling...

Studying dose-dependent endothelio- and cardioprotective activity of selective arginase II inhibitor in hyperhomocysteineinduced endothelial dysfunction

Yakushev, V. I.
Filippenko, N. G.
Kizilova, I. V.
Korokin, M. V.
Beskhmelnitsyna, E. A.

January 2016

This paper deals with the study of endothelio- and cardioprotective activity ofarginase II selective...

A new strategy to treat hyperhomocysteinemia

Geng Bin
Chang Lin
Du Jun-bao
Tang Chao-shu

January 2005

Hyperhomocysteinemia is an independent risk factor for cardiovascular diseases. At present, the main...

Homocysteine and coronary atherosclerosis

Mayer, Ellen L.
Jacobsen, Donald W.
Robinson, Killian

March 1996

AbstractHomocysteine is increasingly recognized as a risk factor for coronary artery disease. An und...

Hyperhomocysteinemia in developing age and nutritional aspects of folates: an early cardiovascular risk factor

Giuseppe Caramia
Romualdo Belardinelli

February 2016

elevated plasma levels of homocysteine are associated with an increased risk of atherosclerosis and ...

Endothelio- and cardioprotective effects of vitamin B₆ and folic acid in modelling methionine-induced hyperhomocysteinemia

Abstract

Extracted data

Endothelio- and cardioprotective effects of vitamin B₆ and folic acid in modelling methionine-induced hyperhomocysteinemia

Abstract

Extracted data

Related items

Related items